Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00619Imatinib2Suspended1